Showing results (41-50 of 616) with videos related to
Sort By:
Pageof 62
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic factors in allogeneic bone marrow transplantation for multiple myelomaG Gahrton, S Tura, P Ljungman, et al.European Journal of Haematology|August 1, 1997
Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomaP L Zinzani, M Bendandi, M Magagnoli, et al.The New England Journal of Medicine|October 31, 1991
Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow TransplantationG Gahrton, S Tura, P Ljungman, et al.Zentralblatt Fur Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B|November 1, 1989
S-phase evaluation with bromodeoxyuridine in lymphocytes from cattle infected with bovine leukemia virus (BLV)P L Tazzari, M Cipone, C Tassi, et al.Acta Haematologica|January 1, 1979
Management of nodular sclerosis Hodgkin's disease stage I, II A and B: evidence for a beneficial effect of MOPP on the relapse rateF Lauria, M Baccarani, L Babini, et al.British Journal of Haematology|October 1, 1983
E-rosette positive acute lymphoblastic leukaemia in adolescents and adultsM Baccarani, S Amadori, R Willemze, et al.Haematologica|April 28, 2001
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantationP Tosi, S Ronconi, E Zamagni, et al.European Journal of Haematology. Supplementum|January 1, 1989
Allogeneic bone marrow transplantation in patients with multiple myelomaG Gahrton, S Tura, C Belanger, et al.British Journal of Haematology|December 1, 1994
Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cellsR M Lemoli, A Fortuna, A Grande, et al.Pageof 62